Replies to post #88556 on Biotech Values

[DewDiligence]

I'd have preferred that they make this secondary 50% larger and keep more of their research staff.

Nitpick: this is a follow-on offering, not a secondary. A secondary offering is one in which the selling shareholder(s) are not the company itself.